A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

October 26, 2023

Primary Completion Date

November 13, 2024

Study Completion Date

December 11, 2024

Conditions
Psoriasis
Interventions
DRUG

SAR441566

Tablet

DRUG

Placebo

Tablet

Trial Locations (53)

1060

Investigational Site Number : 0320001, Buenos Aires

1083

Investigational Site Number : 3480003, Budapest

4032

Investigational Site Number : 3480002, Debrecen

6000

Investigational Site Number : 2680002, Batumi

10117

Investigational Site Number : 2760003, Berlin

15827

Investigational Site Number : 2760004, Blankenfelde-Mahlow

28040

Investigational Site Number : 7240005, Madrid

28041

Investigational Site Number : 7240004, Madrid

33012

Direct Helpers Medical Center Inc- Site Number : 8400023, Hialeah

33134

Driven Research, LLC- Site Number : 8400012, Coral Gables

33175

FXM Clinical Research Miami, LLC- Site Number : 8400016, Miami

33308

FXM Clinical Research Ft. Lauderdale, LLC Site Number : 8400015, Fort Lauderdale

33431

Daxia Trials Site Number : 8400022, Boca Raton

33991

Renaissance Research and Medical Group, Inc- Site Number : 8400018, Cape Coral

38039

Investigational Site Number : 7920001, Kayseri

40225

Investigational Site Number : 1000001, Düsseldorf

46940

Investigational Site Number : 7240003, Manises

50009

Investigational Site Number : 7240002, Zaragoza

58453

Investigational Site Number : 2760002, Witten

60590

Investigational Site Number : 2760001, Frankfurt am Main

72218

Investigational Site Number : 4800001, Quatre Bornes

77004

Center for Clinical Studies, LTD. LLP- Site Number : 8400007, Houston

77598

Center for Clinical Studies, LTD, LLP- Site Number : 8400013, Webster

84095

Jordan Valley Dermatology Center- Site Number : 8400027, South Jordan

85260

Scottsdale Clinical Trials Site Number : 8400025, Scottsdale

90045

Dermatology Research Associates- Site Number : 8400019, Los Angeles

310009

Investigational Site Number : 1560001, Hangzhou

610017

Investigational Site Number : 1560002, Wuxi

7580206

Investigational Site Number : 1520003, Santiago

7640881

Investigational Site Number : 1520001, Santiago

8330034

Investigational Site Number : 1520004, Santiago

8420383

Investigational Site Number : 1520002, Santiago

C1023AAB

Investigational Site Number : 0320003, CABA

C1425DKG

Investigational Site Number : 0320002, CABA

N6H 5L5

Investigational Site Number : 1240006, London

N2J 1C4

Investigational Site Number : 1240002, Waterloo

602 00

Investigational Site Number : 2030003, Brno

0179

Investigational Site Number : 2680001, Tbilisi

861-3106

Investigational Site Number : 3920004, Kamimashiki Gun

593-8324

Investigational Site Number : 3920003, Sakai-shi

173-8610

Investigational Site Number : 3920006, Itabashi-ku

190-0023

Investigational Site Number : 3920002, Tachikawa-shi

272-0033

Investigational Site Number : 3920005, Ichikawa-shi

221-0825

Investigational Site Number : 3920001, Yokohama

85-796

Investigational Site Number : 6160001, Bydgoszcz

40-081

Investigational Site Number : 6160002, Katowice

4810-061

Investigational Site Number : 6200003, Guimarães

1649-035

Investigational Site Number : 6200002, Lisbon

1998-018

Investigational Site Number : 6200001, Lisbon

08041

Investigational Site Number : 7240001, Barcelona

03010

Investigational Site Number : 7240007, Alicante

07070

Investigational Site Number : 7920002, Antalya

M23 9QZ

Investigational Site Number : 8260001, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY